| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0304-3940(99)00762-4 |
| P698 | PubMed publication ID | 10624794 |
| P50 | author | Carla Cannizzaro | Q59691316 |
| P2093 | author name string | P Jenner | |
| A Owen | |||
| S Rose | |||
| B Dass | |||
| B C Tel | |||
| B Y Zeng | |||
| P2860 | cites work | Chronicl-DOPA treatment differentially regulates gene expression of glutamate decarboxylase, preproenkephalin and preprotachykinin in the striatum of 6-hydroxydopamine-lesioned rat | Q71965806 |
| Chronic CP-55,940 alters cannabinoid receptor mRNA in the rat brain: an in situ hybridization study | Q72110282 | ||
| Dopaminergic regulation of cannabinoid receptor mRNA levels in the rat caudate-putamen: an in situ hybridization study | Q72656516 | ||
| Structure of a cannabinoid receptor and functional expression of the cloned cDNA | Q28240076 | ||
| Molecular characterization of a peripheral receptor for cannabinoids | Q28298338 | ||
| D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons | Q29615480 | ||
| Neuronal localization of cannabinoid receptors in the basal ganglia of the rat. | Q34602111 | ||
| Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system | Q34745063 | ||
| Complete coding sequence of rat tyrosine hydroxylase mRNA | Q36390699 | ||
| Neurotransmitters and neuromodulators in the basal ganglia | Q36586002 | ||
| Distribution of neuronal cannabinoid receptor in the adult rat brain: a comparative receptor binding radioautography and in situ hybridization histochemistry | Q38331458 | ||
| Glutamatergic regulation of striatal peptide gene expression in rats | Q47994655 | ||
| Effects of intranigral cannabinoids on rotational behavior in rats: interactions with the dopaminergic system | Q49060851 | ||
| Circling behavior in rats with partial, unilateral nigro-striatal lesions: Effect of amphetamine, apomorphine, and DOPA | Q57913305 | ||
| L-DOPA reverses altered gene expression of substance P but not enkephalin in the caudate-putamen of common marmosets treated with MPTP | Q71589628 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 71-74 | |
| P577 | publication date | 1999-12-01 | |
| P1433 | published in | Neuroscience Letters | Q7002625 |
| P1476 | title | Chronic L-DOPA treatment increases striatal cannabinoid CB1 receptor mRNA expression in 6-hydroxydopamine-lesioned rats | |
| P478 | volume | 276 |
| Q27324171 | A53T-alpha-synuclein overexpression impairs dopamine signaling and striatal synaptic plasticity in old mice |
| Q35166600 | Biosynthesis of endocannabinoids and their modes of action in neurodegenerative diseases |
| Q47850781 | Cannabinoid CB1 and CB2 Receptors, and Monoacylglycerol Lipase Gene Expression Alterations in the Basal Ganglia of Patients with Parkinson's Disease |
| Q34520143 | Cannabinoids and neuroprotection |
| Q42258332 | Cannabinoids in Parkinson's Disease |
| Q42095959 | Detection of cannabinoid receptors CB1 and CB2 within basal ganglia output neurons in macaques: changes following experimental parkinsonism |
| Q44597458 | Effects of levodopa on endocannabinoid levels in rat basal ganglia: implications for the treatment of levodopa‐induced dyskinesias |
| Q39368845 | Endocannabinoid system in neurodegenerative disorders. |
| Q33751118 | In vivo pharmacology of endocannabinoids and their metabolic inhibitors: therapeutic implications in Parkinson's disease and abuse liability |
| Q41681317 | Interaction between the endocannabinoid and serotonergic system in the exhibition of head twitch response in four mouse strains |
| Q36861976 | Loss of cannabinoid CB1 receptor expression in the 6-hydroxydopamine-induced nigrostriatal terminal lesion model of Parkinson's disease in the rat. |
| Q37924629 | Mechanisms underlying the onset and expression of levodopa-induced dyskinesia and their pharmacological manipulation. |
| Q44451116 | Neuroanatomical relationship between type 1 cannabinoid receptors and dopaminergic systems in the rat basal ganglia |
| Q37132571 | Neurochemical changes in the striatum of dyskinetic rats after administration of the cannabinoid agonist WIN55,212-2 |
| Q36074595 | New insights on endocannabinoid transmission in psychomotor disorders |
| Q41809772 | Nigrostriatal denervation changes the effect of cannabinoids on subthalamic neuronal activity in rats. |
| Q43875632 | Persistent behavioral sensitization to chronic L-DOPA requires A2A adenosine receptors. |
| Q34673205 | Striatal molecular signature of subchronic subthalamic nucleus high frequency stimulation in parkinsonian rat. |
| Q34267133 | The decrease of dopamine D₂/D₃ receptor densities in the putamen and nucleus caudatus goes parallel with maintained levels of CB₁ cannabinoid receptors in Parkinson's disease: a preliminary autoradiographic study with the selective dopamine D₂/D₃ an |
| Q27026491 | The dynamic nature of type 1 cannabinoid receptor (CB(1) ) gene transcription |
| Q37394164 | The endocannabinoid system as a target for the treatment of motor dysfunction |
| Q34098196 | The endocannabinoid system as a target for the treatment of neurodegenerative disease |
| Q24648473 | The endocannabinoid system as an emerging target of pharmacotherapy |
| Q34786832 | The endogenous cannabinoid system and the basal ganglia. biochemical, pharmacological, and therapeutic aspects. |
| Q36341688 | The therapeutic potential of drugs that target cannabinoid receptors or modulate the tissue levels or actions of endocannabinoids |
| Q42511788 | Up-regulation of secretoneurin immunoreactivity and secretogranin II mRNA in rat striatum following 6-hydroxydopamine lesioning and chronic L-DOPA treatment |
Search more.